Metabolic phenotype of skeletal muscle in early critical illness

Thorax

Volumn 73, Issue 10, 2018, Pages 926-935

  Puthucheary, Zudin A ^a,b,c   Astin, Ronan ^a   McPhail, Mark J W ^d,e   Saeed, Saima ^f   Pasha, Yasmin ^d   Bear, Danielle E ^c,g,h   Constantin, Despina ⁱ   Velloso, Cristiana ^c   Manning, Sean ^a,j,k   Calvert, Lori ^l   Singer, Mervyn ^b,f   Batterham, Rachel L ^a,j   Gomez Romero, Maria ^m   Holmes, Elaine ^m   Steiner, Michael C ⁿ   Atherton, Philip J ⁱ   Greenhaff, Paul ⁱ   Edwards, Lindsay M ^o   Smith, Kenneth ⁱ   Harridge, Stephen D ^c   Hart, Nicholas ^h   Montgomery, Hugh E ^a   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d ST MARY S HOSPITAL   (United Kingdom)

^e KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^g GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^h ST THOMAS HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^j UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^k UNIVERSITY COLLEGE CORK   (Ireland)

^l PETERBOROUGH CITY HOSPITAL   (United Kingdom)

^m IMPERIAL COLLEGE LONDON   (United Kingdom)

ⁿ UNIVERSITY OF LEICESTER   (United Kingdom)

^o GLAXOSMITHKLINE   (United Kingdom)

more..

Author keywords

ARDS; respiratory muscles

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; ADIPONECTIN; CREATINE; CREATINE PHOSPHATE; GHRELIN; HEMOGLOBIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 10; LEPTIN; MITOCHONDRIAL DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHORYLCHOLINE; TUMOR NECROSIS FACTOR RECEPTOR 1;

APACHE; ARTICLE; BIOENERGY; BIOSYNTHESIS; BLOOD OXYGEN TENSION; CHRONIC DISEASE; CONTROLLED STUDY; CRITICAL ILLNESS; FATTY ACID OXIDATION; FEMALE; GENE DOSAGE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INFLAMMATION; INTENSIVE CARE; LIPID OXIDATION; MAJOR CLINICAL STUDY; MALE; METABOLISM; MITOCHONDRIAL BIOGENESIS; MUSCLE BIOPSY; MUSCLE MASS; MYOSITIS; PGC1ALPHA GENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SKELETAL MUSCLE; VASTUS LATERALIS MUSCLE; ADULT; CLINICAL TRIAL; ENERGY METABOLISM; INTENSIVE CARE UNIT; MIDDLE AGED; MITOCHONDRION; MUSCLE ATROPHY; PHYSIOLOGY;

ADULT; CRITICAL ILLNESS; ENERGY METABOLISM; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MITOCHONDRIA; MUSCLE, SKELETAL; MUSCULAR ATROPHY; PHENOTYPE;

EID: 85049674625     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2017-211073     Document Type: Article

References (61)

1. Puthucheary ZA, Rawal J, McPhail M, et al. Acute skeletal muscle wasting in critical illness. JAMA 2013;310:1591-600.
2. Herridge MS, Cheung AM, Tansey CM, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003;348:683-93.
3. Ali NA, O'Brien JM, Hoffmann SP, et al. Acquired weakness, handgrip strength, mortality in critically ill patients. Am J Respir Crit Care Med 2008;178:261-8.
4. Heyland DK, Stapleton RD, Mourtzakis M, et al. Combining nutrition and exercise to optimize survival and recovery from critical illness: Conceptual and methodological issues. Clin Nutr 2016;35:1196-206.
5. Casaer MP, Mesotten D, Hermans G, et al. Early versus late parenteral nutrition in critically ill adults. N Engl J Med 2011;365:506-17.
6. Heidegger CP, Berger MM, Graf S, et al. Optimisation of energy provision with supplemental parenteral nutrition in critically ill patients: A randomised controlled clinical trial. Lancet 2013;381:385-93.
7. Rice TW, Wheeler AP, Thompson BT, et al. Initial trophic vs full enteral feeding in patients with acute lung injury: The EDEN randomized trial. JAMA 2012;307:795-803.
8. Doig GS, Simpson F, Sweetman EA, et al. Early parenteral nutrition in critically ill patients with short-term relative contraindications to early enteral nutrition: A randomized controlled trial. JAMA 2013;309:2130-8.
9. Denehy L, Skinner EH, Edbrooke L, et al. Exercise rehabilitation for patients with critical illness: A randomized controlled trial with 12 months of follow-up. Crit Care 2013;17:R156.
10. Morris PE, Berry MJ, Files DC, et al. Standardized Rehabilitation and Hospital Length of Stay Among Patients With Acute Respiratory Failure: A Randomized Clinical Trial. JAMA 2016;315:2694-702.
11. Walsh TS, Salisbury LG, Merriweather JL, et al. Increased hospital-based physical rehabilitation and information provision after intensive care unit discharge: The RECOVER randomized clinical trial. JAMA Intern Med 2015;175:901-10.
12. Moss M, Nordon-Craft A, Malone D, et al. A randomized trial of an intensive physical therapy program for patients with acute respiratory failure. Am J Respir Crit Care Med 2016;193:1101-10.
13. CoMN R. The role of protein and amino acids in sustaining and enhancing performance: National Academies Press, 1999.
14. Kafri M, Metzl-Raz E, Jona G, et al. The cost of protein production. Cell Rep 2016;14:22-31.
15. Brealey D, Brand M, Hargreaves I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002;360:219-23.
16. Fredriksson K, Hammarqvist F, Strigård K, et al. Derangements in mitochondrial metabolism in intercostal and leg muscle of critically ill patients with sepsis-induced multiple organ failure. Am J Physiol Endocrinol Metab 2006;291:E1044-E1050.
17. Casaer MP, Wilmer A, Van den Berghe G. Supplemental parenteral nutrition in critically ill patients. Lancet 2013;381:1715.
18. Jaffer U, Wade RG, Gourlay T. Cytokines in the systemic inflammatory response syndrome: A review. HSR Proc Intensive Care Cardiovasc Anesth 2010;2:161-75.
19. Bar-Or D, Carrick MM, Mains CW, et al. Sepsis, oxidative stress, hypoxia: Are there clues to better treatment? Redox Rep 2015;20:193-7. RER11325.
20. Creteur J, Carollo T, Soldati G, et al. The prognostic value of muscle StO2 in septic patients. Intensive Care Med 2007;33:1549-56.
21. Connolly E, Braunstein S, Formenti S, et al. Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells. Mol Cell Biol 2006;26:3955-65.
22. Crossland H, Constantin-Teodosiu D, Greenhaff PL, et al. Low-dose dexamethasone prevents endotoxaemia-induced muscle protein loss and impairment of carbohydrate oxidation in rat skeletal muscle. J Physiol 2010;588(Pt 8):1333-47.
23. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med 2011;364:656-65.
24. Carré JE, Orban JC, Re L, et al. Survival in critical illness is associated with early activation of mitochondrial biogenesis. Am J Respir Crit Care Med 2010;182:745-51.
25. Harris RC, Hultman E, Nordesjö LO. Glycogen, glycolytic intermediates and high-energy phosphates determined in biopsy samples of musculus quadriceps femoris of man at rest. Methods and variance of values. Scand J Clin Lab Invest 1974;33:109-20.
26. Anwar MA, Vorkas PA, Li JV, et al. Optimization of metabolite extraction of human vein tissue for ultra performance liquid chromatography-mass spectrometry and nuclear magnetic resonance-based untargeted metabolic profiling. Analyst 2015;140:7586-97.
27. Austin S, St-Pierre J. PGC1and mitochondrial metabolism-emerging concepts and relevance in ageing and neurodegenerative disorders. J Cell Sci 2012;125(Pt 21):4963-71.
28. Archer SL. Mitochondrial dynamics-mitochondrial fission and fusion in human diseases. N Engl J Med 2013;369:2236-51.
29. CFaAE R. Model-based clustering, discriminant analysis and density estimation. Journal of the American Statistical Association 2002;97:611-31.
30. Shannon P, Markiel A, Ozier O, et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res 2003;13:2498-504.
31. Kyriacou DN. The enduring evolution of the P value. JAMA 2016;315:1113-5.
32. Constantin D, McCullough J, Mahajan RP, et al. Novel events in the molecular regulation of muscle mass in critically ill patients. J Physiol 2011;589(Pt 15):3883-95.
33. Crossland H, Constantin-Teodosiu D, Gardiner SM, et al. A potential role for Akt/FOXO signalling in both protein loss and the impairment of muscle carbohydrate oxidation during sepsis in rodent skeletal muscle. J Physiol 2008;586(22):5589-600.
34. Puthucheary ZA, Phadke R, Rawal J, et al. Qualitative ultrasound in acute critical illness muscle wasting. Crit Care Med 2015;43:1603-11.
35. Villalta SA, Rinaldi C, Deng B, et al. Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype. Hum Mol Genet 2011;20:790-805.
36. Chinetti-Gbaguidi G, Staels B. Macrophage polarization in metabolic disorders: Functions and regulation. Curr Opin Lipidol 2011;22:365-72.
37. Vanhorebeek I, Gunst J, Derde S, et al. Insufficient activation of autophagy allows cellular damage to accumulate in critically ill patients. J Clin Endocrinol Metab 2011;96:E633-E645.
38. Deng B, Wehling-Henricks M, Villalta SA, et al. IL-10 triggers changes in macrophage phenotype that promote muscle growth and regeneration. J Immunol 2012;189:3669-80.
39. Parameswaran N, Patial S. Tumor necrosis factor-signaling in macrophages. Crit Rev Eukaryot Gene Expr 2010;20:87-103.
40. Bartels K, Grenz A, Eltzschig HK. Hypoxia and inflammation are two sides of the same coin. Proc Natl Acad Sci USA 2013;110:18351-2.
41. De Saedeleer CJ, Copetti T, Porporato PE, et al. Lactate activates HIF-1 in oxidative but not in Warburg-phenotype human tumor cells. PLoS One 2012;7:e46571.
42. Weber-Carstens S, Schneider J, Wollersheim T, et al. Critical illness myopathy and GLUT4: Significance of insulin and muscle contraction. Am J Respir Crit Care Med 2013;187.
43. Seagroves TN, Ryan HE, Lu H, et al. Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells. Mol Cell Biol 2001;21:3436-44.
44. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-6.
45. Li WG, Gavrila D, Liu X, et al. Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation 2004;109:2221-6.
46. Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta 2007;380:24-30.
47. Nutricia. Oral nutritional supplements. Secondary Oral nutritional supplements. 2015. http://nutricia. co. uk/files/uploads/documents/Nutricia-ONS-Product-Compendium. pdf
48. N utrition A. Secondary. https://www. abbottnutrition. co. uk/products-A nd-services/Abbott-Nutrition-Products/jevity-plus.
49. Kabiven. Secondary. 2014. http://www. kabivenusa. com/pdf/Kabiven-PI.pdf
50. Heyland DK, Dhaliwal R, Jiang X, et al. Identifying critically ill patients who benefit the most from nutrition therapy: The development and initial validation of a novel risk assessment tool. Crit Care 2011;15:R268.
51. Howrylak JA, Moll M, Weiss ST, et al. Gene expression profiling of asthma phenotypes demonstrates molecular signatures of atopy and asthma control. J Allergy Clin Immunol 2016;137:1390-7.
52. Cardoso F, van't Veer LJ, Bogaerts J, et al. 70-Gene signature as an aid to treatment decisions in early-stage breast cancer. N Engl J Med 2016;375:717-29.
53. Unger RH, Orci L. Diseases of liporegulation: New perspective on obesity and related disorders. Faseb J 2001;15:312-21.
54. Puthucheary ZA, Denehy L. Exercise Interventions in Critical Illness Survivors: Understanding Inclusion and Stratification Criteria. Am J Respir Crit Care Med 2015;191:1464-7.
55. Larsen S, Wright-Paradis C, Gnaiger E, et al. Cryopreservation of human skeletal muscle impairs mitochondrial function. Cryo Letters 2012;33:170-6.
56. Meyer A, Charles AL, Zoll J, et al. Cryopreservation with dimethyl sulfoxide prevents accurate analysis of skinned skeletal muscle fibers mitochondrial respiration. Biochimie 2014;100:227-33.
57. Söderlund K, Hultman E. Effects of delayed freezing on content of phosphagens in human skeletal muscle biopsy samples. J Appl Physiol 1986;61:832-5.
58. Reano S, Graziani A, Filigheddu N. Acylated and unacylated ghrelin administration to blunt muscle wasting. Curr Opin Clin Nutr Metab Care 2014;17:236-40.
59. Parry SM, El-Ansary D, Cartwright MS, et al. Ultrasonography in the intensive care setting can be used to detect changes in the quality and quantity of muscle and is related to muscle strength and function. J Crit Care 2015;30:1151.e9-1151.e14.
60. Puthucheary ZA, McNelly AS, Rawal J, et al. Rectus femoris cross-sectional area and muscle layer thickness: Comparative markers of muscle wasting and weakness. Am J Respir Crit Care Med 2017;195:136-8
61. Dong Y, Peng CY. Principled missing data methods for researchers. Springerplus 2013;2:222.